Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
Abstract
Cases of late onset neutropenia (LON) after rituximab therapy have been documented, but few cases have been documented of early onset neutropenia (EON). We present a case report of a patient with mantle cell lymphoma who presented with EON, only 6 days after initiation of rituximab therapy, notable for the shortest duration to EON ever reported in literature. Throughout this paper, we explore the potential pathogenesis and incidence of EON with the help of our unique case.
J Hematol. 2021;10(3):136-138
doi: https://doi.org/10.14740/jh814